-SWS wrote:I would posit that these three practical indicators can suffice in lieu of that sleep study: 1) a marked improvement in perceived quality of sleep, 2) a marked improvement in daytime cognition, and 3) satisfactory SpO2 scores during a simple nocturnal oximetry test.
This discussion regarding follow-up PSG's and oral appliances seems to be in in the context of the PSG as a go/no-go decision in terms of efficacy, and this is certainly a part of the process.
However, non-users of oral appliances particularly should remember that these are typically not "plug-n-play" devices, but adjustable, "titratable" instruments. Therapy generally begins with very little forward mandibular advancement, and gradually progresses, until a combination of a) symptomatic improvement and b) statistical criteria are met.
It is typically at this point that a (repeat) PSG is done, not so much to determine whether the appliance is FUNCTIONAL, but to determine whether the TITRATION of the appliance is OPTIMAL. There is always a balance between what the device is doing to the jaw, and what effect the device is having on OSA.
xPAP "titration" is traditionally done BEFORE therapy is started. The general sense around here is that all xPAP users should have data-capable machines, to monitor subsequent therapy, and I agree. Oral appliance users have no such objective feedback mechanism, short of the "titration-confirmatory" PSG done AFTER therapy well in progress. (Use of adjunctive pulse oximetry is becoming increasingly popular, but I don't think that anyone yet is recommending it as an ALTERNATIVE to machine data.)
The indicators suggested by -SWS are good ones, regardless of the particular therapy for OSA being employed. But unless we're ready to say that they're sufficient for xPAP users as well, I don't think that they can appropriately substitute for a confirmatory PSG for appliance users. Velbor